MediWound (MDWD) Change in Accured Expenses (2017 - 2025)
MediWound (MDWD) posted quarterly Change in Accured Expenses of -$1.1 million for Q2 2025, down 261.84% year-over-year from $679674.8 in Q2 2024, and down 134.18% quarter-over-quarter from $3.2 million in Q4 2024.
MediWound (MDWD) Change in Accured Expenses (2017 - 2025) Analysis & Trends
MediWound's Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$1.1 million for Q2 2025.
- In Q2 2025, Change in Accured Expenses fell 261.84% year-over-year to -$1.1 million; the TTM figure through Jun 2025 stood at $1.8 million (up 379.43% YoY), while the FY2024 annual figure was $1.3 million, up 313.8% from the prior year.
- Change in Accured Expenses for Q2 2025 stood at -$1.1 million, down from $3.2 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $3.2 million in Q4 2024, with the low at -$2.0 million in Q2 2022.
- The 5-year median for Change in Accured Expenses is -$49500.0 (2023), against an average of -$137437.5.
- The sharpest annual moves came in 2021 and 2022: Change in Accured Expenses soared 49600.0% in 2021, then plunged 15637.5% in 2022.
- MediWound's Change in Accured Expenses stood at $990000.0 in 2021, then slipped by 20.81% to $784000.0 in 2022, then soared by 39.41% to $1.1 million in 2023, then soared by 194.42% to $3.2 million in 2024, then plunged by 134.18% to -$1.1 million in 2025.
- Business Quant data shows MDWD's Change in Accured Expenses at -$1.1 million in Q2 2025, $3.2 million in Q4 2024, and -$48000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 212.44 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 61.62 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 68.82 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.10 Mn |
| Jun 30, 2025 | -1.10 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | -48,000.00 |
| Sep 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -304,000.00 |
| Jun 30, 2024 | -304,000.00 |
| Mar 31, 2024 | -1.37 Mn |
| Mar 31, 2024 | -1.37 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -51,000.00 |
| Sep 30, 2023 | -51,000.00 |
| Jun 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -1.90 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Mar 31, 2023 | -1.95 Mn |
| Dec 31, 2022 | 784,000.00 |
| Dec 31, 2022 | 784,000.00 |